This inventor holds 1 USPTO granted patent. Top assignee: Borealis Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lasti Efrinanda Fuaadi: Patent Activity in Medical Innovation
Introduction
Lasti Efrinanda Fuaadi is an inventor associated with Berlin, Germany, and Borealis GmbH. His patent work concerns the potential medical use of CFTR modulators in conditions beyond cystic fibrosis.
Latest Patents
Fuaadi is associated with 1 patent, titled “Medical Use of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators.” The invention describes using a CFTR modulator to prevent or treat diseases involving endothelial or epithelial barrier dysfunction, excluding cystic fibrosis. It also covers pharmaceutical compositions containing a CFTR modulator, kits combining two CFTR modulators, and a treatment method involving administration of a CFTR modulator to a subject in need.
Career Highlights
Fuaadi’s listed patent activity connects his work at Borealis GmbH with research into therapeutic applications of CFTR modulators. The patent describes a potential approach to addressing barrier dysfunction through pharmaceutical treatment.
Collaborations
The listed coworkers associated with Fuaadi include Wolfgang Kübler and Birgitt Gutbier. Their names provide context for the professional network connected with this patent record.
Conclusion
Lasti Efrinanda Fuaadi’s patent focuses on exploring CFTR modulators as a possible treatment for diseases involving endothelial or epithelial barrier dysfunction, extending their proposed use beyond cystic fibrosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile